Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-10-27

Clinical Trial Update: The Leaflex™ Early Feasibility Study [NA]

View source ↗

Summary

The Leaflex Early Feasibility Study for aortic valve stenosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Pi-cardia | Conditions: Aortic Valve Stenosis | NA | Status: WITHDRAWN